Description

3,4-Dihydro-2,5,7,8-Tetramethyl-2-(4,8,12-Trimethyltridecyl)-2H-Benzopyran-6-Yl Dihydrogen Phosphate is a phosphorylated derivative of Vitamin E (α-tocopherol), designed to enhance stability and bioavailability for advanced applications. This compound matters as a high-value, water-soluble antioxidant and nutrient precursor, offering superior handling and formulation properties compared to its non-phosphorylated counterparts. It is primarily needed by manufacturers in the pharmaceutical, nutraceutical, and high-end cosmetic industries seeking innovative active ingredients for injectable, oral, and topical delivery systems.

Application

• Pharmaceutical Intermediates: Key starting material or intermediate in the synthesis of advanced Vitamin E-based therapeutics and prodrugs.
• Nutraceutical Formulations: Used in premium dietary supplements and functional foods for its enhanced antioxidant bioavailability and stability in aqueous systems.
• Cosmetic Actives: Incorporated into anti-aging serums, creams, and lotions for its skin-protective and regenerative properties.
• Biochemical Research: Serves as a critical reagent in life science research for studying antioxidant mechanisms, cell signaling, and lipid metabolism.
• Animal Nutrition: Applied in high-performance feed additives to improve animal health and product quality through potent antioxidant activity.
• Advanced Material Stabilizers: Potential use as a stabilizer in sensitive polymer or coating formulations requiring a phosphate-based antioxidant.

Basic Information

Product Name	3,4-Dihydro-2,5,7,8-Tetramethyl-2-(4,8,12-Trimethyltridecyl)-2H-Benzopyran-6-Yl Dihydrogen Phosphate
CAS No.	2312-88-1
Molecular Formula	C33H59O6P
Molecular Weight	582.79 g/mol
Synonyms	Vitamin E Phosphate; d-α-Tocopheryl Phosphate; Tocopheryl Phosphate; 2,5,7,8-Tetramethyl-2-(4,8,12-trimethyltridecyl)-6-chromanol Phosphate; α-Tocopherol Phosphate; 6-Hydroxy-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chroman-6-yl Dihydrogen Phosphate; TPNa (as sodium salt derivative); Tocofersolan related compound
EINECS	219-023-8

Quality Control

Our 3,4-Dihydro-2,5,7,8-Tetramethyl-2-(4,8,12-Trimethyltridecyl)-2H-Benzopyran-6-Yl Dihydrogen Phosphate is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets exacting standards suitable for pharmaceutical and nutraceutical development. Certificates of Analysis (COA) documenting purity, assay, and impurity profiles are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its sensitivity to oxidation, long-term storage under an inert atmosphere (e.g., nitrogen or argon) is recommended for optimal stability. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white powder or crystalline solid
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 95.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.